Welcome to LookChem.com Sign In|Join Free
  • or
Boc-Glu(OBn)-Gly-OtBu is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

945979-59-9

Post Buying Request

945979-59-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

945979-59-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 945979-59-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,9,7 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 945979-59:
(8*9)+(7*4)+(6*5)+(5*9)+(4*7)+(3*9)+(2*5)+(1*9)=249
249 % 10 = 9
So 945979-59-9 is a valid CAS Registry Number.

945979-59-9Relevant academic research and scientific papers

Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I

More, Swati S.,Vince, Robert

, p. 3793 - 3797 (2007)

The known affinity of ethyl acetoacetate (ACC) toward divalent zinc prompted us to attempt its employment as a chelating moiety in the design of glyoxalase-I inhibitors. A practical synthetic route was developed to incorporate this pharmacophore into the side chain of glutamic acid, with flexibility to allow incorporation of additional functionality at the end-stage of the synthesis. Herein, the details of this synthetic approach as well as the evaluation of the resultant β-keto ester compounds are reported.

Inhibition of glyoxalase I: The first low-nanomolar tight-binding inhibitors

More, Swati S.,Vince, Robert

supporting information; experimental part, p. 4650 - 4656 (2010/03/01)

A series of rational modifications to the structure of known S-(N-aryl-N-hydroxycarbamoyl)glutathione-based glyoxalase I inhibitors culminated in the discovery of the first single-digit nanomolar inhibitor. This study makes available key information about possible means to address the issues of metabolic instability, low potency, and synthetic complexicity that have plagued the area of glyoxalase I inhibition. Knowledge garnered from this study has implications in the design of inhibitors with higher conformational definition and lower peptidic character.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 945979-59-9